Related Experiment Video
Updated: May 13, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Prostate cancer prevention: strategies for agent development
Howard L Parnes1, Margaret G House, Joseph A Tangrea
1Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892, USA. parnesh@mail.nih.gov
Clinical trials for prostate cancer chemoprevention show mixed results. While some agents like 5-α-reductase inhibitors demonstrated benefits, others like vitamin E and selenium did not prove effective for cancer prevention.
Area of Science:
- Oncology
- Preventive Medicine
- Clinical Pharmacology
Background:
- The National Cancer Institute supports research into agents for prostate cancer chemoprevention.
- Chemoprevention aims to delay, prevent, or reverse carcinogenesis to reduce cancer incidence.
Purpose of the Study:
- To provide an update on clinical research within the National Cancer Institute's prostate cancer chemoprevention agent development program.
- To review findings from Phase I/II and Phase III clinical trials evaluating pharmacologic interventions for prostate cancer prevention.
Main Methods:
- Review of numerous clinical trials, including small biomarker-focused studies and large population-based trials with cancer endpoints.
- Analysis of data from Phase III prostate cancer prevention trials investigating specific agents and combinations.
Main Results:
- Two large Phase III trials indicated a significant benefit for 5-α-reductase inhibitors in prostate cancer prevention, but with increased detection of high-grade cancers.
- A separate Phase III trial found no benefit for selenium or vitamin E, with vitamin E alone associated with an increased risk of prostate cancer.
Conclusions:
- Extensive research, including early phase and three definitive Phase III trials, has advanced prostate cancer prevention strategies.
- Despite progress, further research is necessary to fully harness the potential of chemoprevention for prostate cancer.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Prevention
Some...
Cancer Prevention
Some...
Preventive Healthcare Services
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Preclinical Development: Overview

